2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details


臨床試験数 : 624 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225

  
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01786603
(ClinicalTrials.gov)
November 21, 201328/11/2012Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis (ALS)Drug: Rasagiline;Drug: PlaceboRichard Barohn, MDNULLCompleted21 Years80 YearsAll80Phase 2United States
2NCT01879241
(ClinicalTrials.gov)
June 201312/6/2013Study of Rasagiline in Patients With Amyotrophic Lateral SclerosisEfficacy, Safety and Tolerability Study of 1 mg Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS) Receiving Standard Therapy (Riluzole) - An AMG Trial With a Market Authorized SubstanceAmyotrophic Lateral SclerosisDrug: Rasagiline;Drug: PlaceboUniversity of UlmNULLCompleted18 YearsN/ABoth252Phase 2Germany
3EUCTR2011-004482-32-DE
(EUCTR)
10/04/201321/12/2012Efficacy, Safety and Tolerability Study of 1 mg Rasagiline in Patients with Amyotrophic Lateral Sclerosis (ALS) Receiving Standard Therapy (Riluzole)Efficacy, Safety and Tolerability Study of 1 mg Rasagiline in Patients with Amyotrophic Lateral Sclerosis (ALS) Receiving Standard Therapy (Riluzole) - RAS-ALS Trial Amyotrophic Lateral Sclerosis (ALS)
MedDRA version: 14.1;Level: PT;Classification code 10002026;Term: Amyotrophic lateral sclerosis;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Trade Name: AZILECT® 1 mg Tabletten
INN or Proposed INN: Rasagiline Mesilate
Other descriptive name: RASAGILINE MESILATE
Universitätsklinikum UlmNULLNot RecruitingFemale: yes
Male: yes
Phase 2Germany
4NCT01232738
(ClinicalTrials.gov)
December 201122/10/2010Trial of Safety and Efficacy of Rasagiline in Patients With Amyotrophic Lateral Sclerosis (ALS)A Multi-Center Controlled Screening Trial of Safety and Efficacy of Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosis (ALS)Drug: rasagilineYunxia Wang, MDWestern ALS Study GroupCompleted21 Years80 YearsAll36Phase 2United States;Canada